Biomedecine & pharmacotherapie 影响因子

WebJan 23, 2024 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2024-12-16 Journal article DOI: 10.1016/j.biopha.2024.111115 PMID: 33341046 Show more detail. Source: Jie Mei LncRNA SNHG3, a potential oncogene in human cancers. Cancer cell international 2024 ... Web全名/缩写: biomedicine & pharmacotherapy biomed pharmacother: 期刊issn: 0753-3322: 2024-2024影响因子: 3.460: 最新自引率: 10.80%: 期刊官方网站

PubMedPro - 可以显示IF影响因子的文献检索网站

Web《Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie》共发表3128篇文献，掌桥科研收录1999年以来所有《Biomedicine & pharmacotherapy =: … Web影响因子,sci期刊影响因子,2024影响因子预测,2024影响因子,英文期刊,中文核心期刊,中科院分区查询,科技核心,北大核心,分区查询,cscd churches amelia island florida https://haleyneufeldphotography.com

Biomedicine & Pharmacotherapy - Wikipedia

WebBiomedicines is an international, scientific, peer-reviewed, open access journal on biomedicines published monthly online by MDPI. The Society for Regenerative Medicine (Russian Federation) (RPO) is affiliated with Biomedicines and its members receive discounts on the article processing charges. Open Access — free for readers,with article … Web晟斯医学整理了biomedicine & pharmacotherapy期刊影响因子数据，中科院jcr分区与学科排名数据，citescore学科排名数据，期刊的基础信息参数与简介，通过页面下方的投稿经 … Web介绍. Biomedicine & Pharmacotherapy is a multidisciplinary journal which publishes full-length, original research reports, reviews, and preliminary communications or letters to the editor which fall within the general scope of clinical and basic medicine and pharmacology. churches and osha requirements

Biomedicine & Pharmacotherapy 5年平均影响因子 ... - Justscience

Category:新晋SCI：Biomedicines，初审15.1天，首个影响因子超4分

Tags:Biomedecine & pharmacotherapie 影响因子

Biomedecine & pharmacotherapie 影响因子

Biomedicine & Pharmacotherapy 5年平均影响因子 ... - Justscience

WebFive hours after the BCR inhibition test, a fall of 83% in PRL plasma levels (from 8,336 μg/L to 1,417 μg/L), and of 91.6% in GH plasma levels (from 39.5 μg/L to 3.3 μg/L) were … WebBIOMEDICINE & PHARMACOTHERAPY. 出版年份：1982 年文章数：1010 投稿命中率：58.59%. 出版周期：Bimonthly 自引率：10.8% 审稿周期：平均1.73月. 前往期刊查询. 期刊讨论 中国SCI论文 期刊主页 投稿经验 杂志官网 投稿链接 作者需知 PMC链接 Pubmed全文检索. 期刊论坛.

Biomedecine & pharmacotherapie 影响因子

Did you know?

Web影响因子分析以及预测. Acta Pharmaceutica Sinica B 于2024年6月被SCIE收录，收录内容从2015年第1期开始。. 拥有影响因子的时间并不长，2024年才获得第一个影响因子6.014，虽然2024年影响因子有所下降，但是不影响总体的增长趋势。. 2024-2024年的SCI影响因子分别为6.014、5. ... http://med.wanfangdata.com.cn/Periodical/8213295

Web今天带大家一起了解的是一本 医学领域下的多学科期刊——BIOMEDICINE&PHARMACOTHERAPY，主要发表完整的原创研究报告、评 … WebBiomedicine & Pharmacotherapy is a multidisciplinary journal which publishes full-length, original research reports, reviews, and preliminary communications or letters to the editor …

WebBiomedicine & Pharmacotherapy is a multidisciplinary journal which publishes full-length, original research reports, reviews, and preliminary communications or letters to the editor which fall within the general scope of clinical and basic medicine and pharmacology. The general fields of interest will include Cancer, Nutriceutics ... http://www.mebis.cn/sci/detail.php?id=1568

WebPubMed.pro是医学,生命科学领域的数据库,简洁易用的PubMed中文版,PubMed手机版, 支持中英文关键词检索,标题摘要翻译,自动显示期刊影响因子，桌面手机均可使用

Web《Biomedicines》发布于爱科学网，并永久归类相关SCI期刊导航类别中，本站只是硬性分析 "《》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积 … churches and cathedrals in turinWeb影响因子（IF）经常用作表明期刊对其领域重要性的指标。. 它是由科学信息研究所的创始人Eugene Garfield首次提出的。. 尽管IF被机构和临床医生广泛使用，但是人们对于IF日记 … churches and money launderingWebBiomedicine & Pharmacotherapy is a multidisciplinary journal which publishes full-length, original research reports, reviews, and preliminary communications or letters to the editor which fall within the general scope of clinical and basic medicine and pharmacology. The general fields of interest …. View full aims & scope. $3050*. churches and lines of credit good or badWebPubMed Central (PMC)链接：PubMed Central 平均审稿速度：网友分享经验：平均2月 来源Elsevier官网：平均7周 平均录用比例：网友分享经验：约50% 在线出版周期： devan hilton obituaryWebJul 31, 2024 · 一群90后药丸子致力于为大家提供更好的学习平台 churches and schools for saleWebBiomedicine & Pharmacotherapy is a peer-reviewed medical journal covering medical applications of pharmacology. It was established in 1956 and is published ten times a year by Elsevier, which has been publishing the journal since 1988. [1] [failed verification] The editor-in-chief is D.M. Townsend ( Medical University of South Carolina ). devanlay by lmp sprimontWebBIOMEDICINE & PHARMACOTHERAPY. 出版年份：1982 年文章数：1010 投稿命中率：58.59%. 出版周期：Bimonthly 自引率：10.8% 审稿周期：平均1.73月. 前往期刊查询. … devanney law firm